Tag:
Massmart
Ghost Wrap
Ghost Wrap #6 (MTN + Telcos | Steinhoff | Alviva | Mpact | PBT Group | Shoprite – Massmart | Grand Parade)
Telcos. Steinhoff. A take-private of Alviva. These are just some of the important updates in the final edition of Ghost Wrap for 2022.
DealMakers
Who’s doing what this week in the South African M&A space?
Weekly summary of Merger & Acquisition activity by South African companies
Ghost Bites
Ghost Bites (Aspen | Ellies | Northam Platinum – Royal Bafokeng Platinum | PBT Group | Shoprite – Massmart)
Aspen takes a big step for vaccines in Africa
This deal includes the receipt of $30 million in funding
Back in August, Aspen announced an agreement...
Consumer and Retail
The delisting date for Massmart is confirmed
With all conditions now met, Massmart and Walmart will proceed with implementation of the scheme. The real work starts now to improve the business.
Consumer and Retail
Massmart shareholders say yes to Walmart
Shareholders are advised that at the General Meeting held today, Friday, 21 October 2022, convened to consider and approve the Scheme Resolution and the Delisting Resolution, all of the resolutions tabled were approved by the requisite majority of Massmart Shareholders present or represented by proxy and entitled to vote thereon.
Ghost Bites
Ghost Bites (Altron | Dis-Chem | Fortress | Gemfields | Massmart | South32)
Altron reports a sharp recovery in profitability. Dis-Chem keeps winning market share. Fortress might avoid losing REIT status. Gemfields is under armed guard in Mozambique. South32's quarterly report is promising.
Ghost Bites
Ghost Bites (Orion | Raubex | Royal Bafokeng | Spear REIT)
Orion has announced a R250 million funding package. Raubex proves that construction can make money, Royal Bafokeng Platinum suffered a poor quarter. Spear REIT puts in another solid performance.
Chris Gilmour
After DIY stocks have been hammered, are there opportunities?
DIY stocks have taken a beating this year as things cooled off after the pandemic. Are we at the point where there are opportunities in the market? Chris Gilmour gives us his view.
